CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.
The Brighterside of News on MSN
AI-powered CRISPR technology turbocharges gene therapy development
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...
CRISPR Therapeutics (CRSP) announced the acceptance of an abstract for oral presentation at the European Society of Gene and Cell Therapy, ESGCT, ...
MedPage Today on MSN
Gene-Editing Therapy Promising for Rare Hereditary Disease
A gene-editing therapy led to durable changes in serum transthyretin levels among people with hereditary transthyretin ...
The report provides a comprehensive analysis of the genome editing market, focusing on technologies like CRISPR-Cas, TALEN, ...
CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR ...
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...
Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...
A team led by scientists at Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and ...
Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback